共 3 条
- [2] The Calcemic Response to Continuous Parathyroid Hormone (PTH)(1-34) Infusion in End-Stage Kidney Disease Varies According to Bone Turnover: A Potential Role for PTH(7-84) JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (06): : 2772 - 2780
- [3] Maxacalcitol therapy suppresses hyperactive parathyroid function with a predominant reduction of authentic 1-84 PTH and a lessor reduction of large C terminal PTH fragments in dialysis patients - Potential explanation for adynamic bone following vitamin D. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 571A - 571A